Matthieu Mahevas

13PUBLICATIONS
19CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyAutoimmunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 17, 2024
What is the best second-line treatment for immune thrombocytopenia?

Matthieu Mahévas, James B Bussel

|Oct 10, 2024
When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?

Sydney Dubois, Richard Layese, Nicolas Limal

|Jan 24, 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.

Guillaume Moulis, Manuela Rueter, Aymeric Duvivier

|Dec 29, 2023
B-cell responses to ITP treatments.

Etienne Crickx, Matthieu Mahévas

|May 29, 2023
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience.

Etienne Crickx, Mikael Ebbo, Etienne Rivière

|Apr 01, 2023
B cells and antibodies in refractory immune thrombocytopenia.

Anaïs Roeser, Alan H Lazarus, Matthieu Mahévas

Pageof 3

Frequent Collaborators

3 joint publications

Lionel Galicier

3 joint publications

Etienne Crickx

3 joint publications

Thibault Comont

2 joint publications

Marion Malphettes